Business Context and Reporting Period
Company: Personalis, Inc. (PSNL)
Filing Type: Form 8-K (Current Report)
Date of Report: July 20, 2026
Reporting Period: The filing references preliminary financial and operational results for the quarter ended June 30, 2026, though specific figures are not included in this text.
Key Financial Metrics
This filing does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. The document states that preliminary financial results for the quarter ended June 30, 2026, are included in the attached Joint Press Release (Exhibit 99.1), but the text of the press release is not provided in the source input.
Material Changes and Corporate Action
Proposed Acquisition: On July 20, 2026, Personalis, Inc. and Tempus AI, Inc. announced a definitive Agreement and Plan of Merger. Under the terms of the agreement:
- Tempus will acquire Personalis through a two-step merger process involving two wholly-owned subsidiaries (Merger Sub I and Merger Sub II).
- Personalis will become a direct, wholly-owned subsidiary of Tempus upon closing.
- The transaction is subject to the terms and conditions of the Merger Agreement, including stockholder approval and regulatory clearances.
Guidance, Outlook, and Risks
Management Commentary: The filing includes extensive forward-looking statements regarding the anticipated benefits, synergies, and integration of the combined company. Management cautions that actual results may differ materially from these projections.
Key Risks and Contingencies:
- Transaction Failure: Risks include failure to obtain stockholder approval, inability to satisfy closing conditions, termination of the agreement, or delays in closing.
- Operational Disruption: Potential diversion of management time, adverse employee reactions, and business disruption during the pendency of the transaction.
- Regulatory and Legal: Risks related to regulatory approvals, potential litigation, and changes in legal or tax regimes.
- Financial Uncertainty: Uncertainty regarding the realization of synergies, operating costs exceeding expectations, and capital market conditions.
Future Filings: Tempus will file a registration statement on Form S-4 (including a proxy statement/prospectus) and a Schedule 13E-3. Investors are urged to read these documents for detailed financial information and voting instructions.
Investor Verification Checklist
- Merger Terms: Verify the specific consideration (cash, stock, or combination) and exchange ratio in the upcoming Form S-4 and proxy statement/prospectus.
- Financial Performance: Review the preliminary Q2 2026 financial results detailed in the Joint Press Release (Exhibit 99.1) and the full audited financials in the S-4.
- Approval Status: Monitor the status of stockholder votes required from both Personalis and Tempus shareholders.
- Regulatory Hurdles: Track the progress of necessary regulatory approvals and clearances for the merger.
- Management Holdings: Review recent Form 4 filings by directors and executive officers (e.g., Dr. Myers, Ms. Bloom, Mr. Hall) for changes in beneficial ownership prior to the merger announcement.